Get 40% Off
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks

Prestige Consumer Gains On Strong Margins & Robust Cash Flow

Published 08/14/2019, 10:45 PM
Updated 07/09/2023, 06:31 AM

Prestige Consumer Healthcare Inc. (NYSE:PBH) is gaining from well-chalked growth strategies, which include acquisitions, strong cash position and solid margin trend. The company’s business transformation efforts, which aim at expansion of healthcare offerings, are also noteworthy.

Let’s delve deeper.

A Brief Introspection

A sturdy margin trend bodes well for Prestige Consumer. Notably, the company’s gross margin expanded 230 basis points (bps) to 57.7% in first-quarter fiscal 2020, driven by the divestiture of the Household Cleaning segment. The company’s margins expanded 160 bps, 310 bps and 220 bps in the second, third and fourth quarters of fiscal 2019, respectively. Continuation of such trends should aid the bottom line in the days ahead. Management envisions adjusted earnings per share of $2.76-$2.83 for fiscal 2020, up from $2.78 reported in the previous year.

Further, Prestige Consumer, which shares space with Funko (NASDAQ:FNKO) , Container Store (NYSE:TCS) and Spectrum Brands (NYSE:SPB) , boasts robust free cash flow. The company generated free cash flow of approximately $51 million in the fiscal first quarter, which helped it reduce debt by $20 million and facilitated share repurchases of roughly $30 million. Management expects adjusted free cash flow of $200 million or more for fiscal 2020.

These apart, strong consumption trends in the healthcare category have prompted Prestige Consumer to transform its business. Well, changing the company name from Prestige Brands Holdings, Inc to Prestige Consumer Healthcare, Inc during the second quarter of fiscal 2019 is a step toward that direction. This move is an important milestone for the company that prides on having a strong portfolio of healthcare brands. Moreover, management stated that focusing on areas that have greater growth prospects, such as healthcare, will help the company utilize resources efficiently.

Additionally, Prestige Consumer pursues mergers and acquisitions to boost growth. In this regard, the acquisition of Fleet in January 2017 is one of the company’s largest transactions. In 2012, Prestige Consumer acquired BC & Goody's, which aided expansion of its distribution channel and customer reach. Moreover, the company is on track with its strategy of improving brands and marketing capabilities of its acquired businesses. In line with this, it recently came up with new packaging for its BC & Goody’s brands. Other noteworthy acquisitions of the company include DenTek Holdings, Inc in 2016 and Hydralyte in 2015. These acquisitions have enhanced the company’s portfolio.

However, a persistent decline in the company’s sales is a concern. Sales declined for the fifth straight time in the first quarter of fiscal 2020. This along with currency headwinds post a threat. Having said that, we hope the company’s solid growth prospects will yield results and counter the aforementioned hurdles.

Breakout Biotech Stocks with Triple-Digit Profit Potential

The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.

Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +98%, +119% and +164% in as little as 1 month. The stocks in this report could perform even better.

See these 7 breakthrough stocks now>>

Spectrum Brands Holdings Inc. (SPB): Free Stock Analysis Report

Prestige Consumer Healthcare Inc. (PBH): Free Stock Analysis Report

Container Store (The) (TCS): Free Stock Analysis Report

Funko, Inc. (FNKO): Free Stock Analysis Report

Original post

Zacks Investment Research

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.